SCHEMBL23733792

SCHEMBL23733792

Fc1ccc(-c2nc(-c3ccc(F)cc3)nc(-c3cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
DPP4 P27487 2/20 0.50
ABCG2 Q9UNQ0 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 3/20 0.47
KDM4E B2RXH2 3/20 0.47
GLA P06280 1/20 0.47
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NTSR1 P30989 1/20 0.46
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23733811 0.98 DPP4 (0.49) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733860 0.98 DPP4 (0.49) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733793 0.96 DPP4 (0.47) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733874 0.96 DPP4 (0.47) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733862 0.96 DPP4 (0.47) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733782 0.96 DPP4 (0.47) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733824 0.94 DPP4 (0.49) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733883 0.94 DPP4 (0.49) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733902 0.93 MEN1 (0.62) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23733853 0.91 L3MBTL1 (0.56) MAPTMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11563183-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-24 US disclosed
US-20210367158-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-25 US disclosed
US-11088331-B2 2021-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11563183-B2 Heterocyclic compound and organic light-emitting device including the same DDT, PPOX, LEF1 MAPT 2315/4885MEN1 1812/4885KMT2A 1533/4885
US-11844273-B2 Heterocyclic compound and organic light-emitting device including the same DDT, PPOX, LEF1 MAPT 2315/4885MEN1 1812/4885KMT2A 1533/4885
US-11088331-B2 DDT, PPOX, DBF4 MAPT 2126/4885MEN1 2173/4885KMT2A 1723/4885
US-20210367158-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME DDT, PPOX, LEF1 MAPT 2315/4885MEN1 1812/4885KMT2A 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.